Author Question: Which of the following problems would the nurse expect to see in a patient undergoing chemotherapy? ... (Read 94 times)

jhjkgdfhk

  • Hero Member
  • *****
  • Posts: 569
Which of the following problems would the nurse expect to see in a patient undergoing chemotherapy? (Select all that apply.)
 
  a. Leukocytosis
  b. Thrombocytopenia
  c. Alopecia
  d. Urinary retention
  e. Stomatitis

Question 2

A patient has taken high-dose glucocorticoids for 2 months for severe asthma. The symptoms have resolved, and the patient is ready to stop the medication. How should the nurse instruct the patient to stop the medication?
 
  a. The dose should be tapered over the course of 7-10 days.
  b. The drug can be stopped immediately if no longer needed.
  c. The drug must be continued for life.
  d. Another glucocorticoid should be used to reduce cross-tolerance.



ynlevi

  • Sr. Member
  • ****
  • Posts: 338
Answer to Question 1

B, C, E
Chemotherapy can cause thrombocytopenia, alopecia, and stomatitis.
Chemotherapy does not cause leukocytosis, but it may cause leucopenia.
Chemotherapy does not cause urinary retention, but it may cause hyperuricemia.

Answer to Question 2

a



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

When Gabriel Fahrenheit invented the first mercury thermometer, he called "zero degrees" the lowest temperature he was able to attain with a mixture of ice and salt. For the upper point of his scale, he used 96°, which he measured as normal human body temperature (we know it to be 98.6° today because of more accurate thermometers).

Did you know?

By definition, when a medication is administered intravenously, its bioavailability is 100%.

Did you know?

It is widely believed that giving a daily oral dose of aspirin to heart attack patients improves their chances of survival because the aspirin blocks the formation of new blood clots.

Did you know?

Women are two-thirds more likely than men to develop irritable bowel syndrome. This may be attributable to hormonal changes related to their menstrual cycles.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library